10x Genomics (TXG) Shares Outstanding (2018 - 2026)

10x Genomics has disclosed Shares Outstanding across 9 years of filings, most recently posting $129.0 million for Q1 2026.

• Shares Outstanding for Q1 2026 came in at $129.0 million, up 4.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $129.0 million (up 4.75% YoY), and the FY2025 annual result was $127.7 million, up 4.42% from the prior year.
• Shares Outstanding came in at $129.0 million for Q1 2026 at 10x Genomics, up from $127.7 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $129.0 million in Q1 2026 to a low of $113.3 million in Q1 2022.
• The 5-year median for Shares Outstanding is $119.7 million (2024), against an average of $120.1 million.
• Across the five-year window, Shares Outstanding climbed 2.38% in 2022 and grew 4.75% in 2026, its largest moves.
• 10x Genomics' Shares Outstanding stood at $115.2 million in 2022, then advanced by 3.39% to $119.1 million in 2023, then rose by 2.68% to $122.3 million in 2024, then gained by 4.42% to $127.7 million in 2025, then grew by 1.02% to $129.0 million in 2026.
• The last three Shares Outstanding figures came in at $129.0 million (Q1 2026), $127.7 million (Q4 2025), and $126.5 million (Q3 2025), per Business Quant data.